Novartis AG Market Cap 2006-2020 | NVS

Novartis AG market cap history and chart from 2006 to 2020. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Novartis AG market cap as of August 06, 2020 is $190.92B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $190.923B $47.498B
Novartis AG is committed to improving health and well-being through innovative products and services. The company aspires to capture and hold a leadership position in all of their businesses with a strong, sustainable performance based on continuous innovation. Their long-term success is founded on meeting the expectations of all our stakeholders - their customers, their people, their shareholders and the communities in which they live and work.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $390.711B 18.62
Roche Holding AG (RHHBY) Switzerland $297.224B 0.00
Pfizer (PFE) United States $213.583B 13.35
Merck (MRK) United States $206.068B 14.74
AbbVie (ABBV) United States $164.571B 10.03
Novo Nordisk (NVO) Denmark $153.274B 25.52
Eli Lilly (LLY) United States $147.622B 22.53
AstraZeneca (AZN) United Kingdom $146.834B 28.55
Sanofi (SNY) $129.239B 15.36
GlaxoSmithKline (GSK) United Kingdom $103.376B 13.56
Bayer (BAYRY) Germany $62.294B 8.98
H Lundbeck (HLUYY) Denmark $7.279B 12.65
Innoviva (INVA) United States $1.360B 6.51